Porphyria

Jump to navigation Jump to search
Porphyria
ICD-10 E80.0-E80.2
ICD-9 277.1
MedlinePlus 001208
MeSH C17.800.849.617

For patient information click here

Porphyria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Porphyria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Porphyria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Porphyria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Porphyria

CDC on Porphyria

Porphyria in the news

Blogs on Porphyria

Directions to Hospitals Treating Porphyria

Risk calculators and risk factors for Porphyria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords:Acute intermittent porphyria; hereditary coproporphyria; congenital erythropoietic porphyria; erythropoietic protoporphyria

Overview

Historical Perspective

Pathophysiology

Differentiating Porphyria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies


Porphyria is considered an absolute contraindication to the use of the following medications:

Acknowledgements

Source of Initial Content: Resident report notes prepared by Duane S. Pinto, M.D. and Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Template:Endocrine, nutritional and metabolic pathology


Template:WikiDoc Sources